MedTrace Logo

Validation of Kujala German

NCT01495507 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2016-07-19

No results posted yet for this study

Summary

The field of patellofemoral disorders and accordant therapeutical interventions is a high turnover research field. It is important to verify the clinical outcome with appropriate measuring tools. There is evidence that the Kujala score is a reliable and widely used measuring instrument of patellofemoral disorders. Indeed, the Kujala score was already used in many studies investigating patellofemoral disorders - also in german speaking patient groups. Unfortunately, we are not aware of a validated german version of the Kujala score. Other relevant knee outcome scores were already successfully translated into german language and validated by previous investigators.

So, it is the aim of our study to cross-culturally adapt and then to validate the Kujala score for use in German-speaking individuals with patellofemoral instability. It is hypothesized that the german version of the Kujala score shows:

* High divergent construct validity as determined by significant differences between patients and controls (hypothesis 1)
* High convergent construct validity as determined by significant correlations with other relevant scoring systems (hypothesis 2)
* High reliability (hypothesis 3)
* High responsiveness (hypothesis 4)

Conditions

  • Validation of Kujala Score German Version in Patients With Patellofemoral Instability and Scheduled MPFL-reconstruction

Interventions

PROCEDURE

MPFL- Reconstruction

Sponsors & Collaborators

  • Medical University Innsbruck

    lead OTHER

Eligibility

Min Age
10 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2017-01-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01495507 on ClinicalTrials.gov